To cite this paper use one of the standards below:
Cancer is one of the leading causes of death in the world today and a major challenge, as conventional therapies such as chemotherapy and radiotherapy can cause several side effects, in addition to developing cellular resistance. Therefore, the search for more effective antitumor agents is growing and antitumor peptides, which are small molecules with activity against cancer, emerge as an interesting alternative, being a promising tool in research. Melittin is a peptide derived from the venom of Apis mellifera, well described in literature, has antitumor activity, but it is not selective and is very toxic to non-tumor cells, which prevents its implementation as a therapeutic tool. Therefore, peptides analogs with better therapeutic efficiency are being studied. The objective of this study was to synthesize, purify and characterize peptides analogs to Melittin, searching for reduced toxicity and increased selectivity. Peptides were synthesized by Solid Phase Peptide Synthesis and purified by High Performance Liquid Chromatography. Functional characterization was performed by evaluating cytotoxic activity in cell lines of breast adenocarcinoma (MCF-7, ATCC HTB-22 and MDA-MB-231, ATCC HTB-26), lung adenocarcinoma (A549, ATCC CCL-185), and non-tumor lung cell line (MRC-5, ATCC CCL-171), clonogenic assay in the same cell lines and hemolytic activity. In this work, 6 peptides were synthesized and purified, named Melittin, LR2204, LR2205, LR2207, AE2211 and AE2214, it was possible to observe that the peptides showed lower cytotoxic activity for the non-tumor cell line compared to Melittin. Peptides LR2205 and LR2207 stood out for the MCF-7 cell line. However, the comparative molecule, which has a well-described effect in the literature, proved to be cytotoxic in all cell lines tested. The peptides showed reduced hemolysis compared to Melittin. For the clonogenic assay, we expect to evaluate the effect of the peptides on colony formation in tested cell lines. Compared to Melittin, the analogs showed lower toxicity and these results can contribute to further studies in the development of more efficient drugs.
With nearly 200,000 papers published, Galoá empowers scholars to share and discover cutting-edge research through our streamlined and accessible academic publishing platform.
Learn more about our products:
This proceedings is identified by a DOI , for use in citations or bibliographic references. Attention: this is not a DOI for the paper and as such cannot be used in Lattes to identify a particular work.
Check the link "How to cite" in the paper's page, to see how to properly cite the paper